Saturday, 10 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

ARAMIS GROUP Stock Bullish By 17% So Far Today

Loading stream...

(vianews) - shares of aramis group (cac 40: arami.pa) rose by a staggering 17.17% to €5.05 at 11:36 est on thursday, after three consecutive sessions in a row of losses. cac 40 is dropping 0.45% to €7,220.65, after three successive sessions in a row of losses. this seems, up to now, a somewhat negative trend trading session today.

about aramis group

aramis group sas engages in the online sale of used cars in europe. the company operates aramisauto, cardoen, and clicars brands in france, belgium, and spain, as well as carsupermarket platform in the united kingdom. aramis group sas was founded in 2001 and is based in arcueil, france.

earnings per share

as for profitability, aramis group has a trailing twelve months eps of €-0.73.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, aramis group's stock is considered to be overbought (>=80).

more news about aramis group (arami.pa).

Categories

stockMarket

Tags

Stock PriceMarket Session NowStock Market NowPrice UpMarket SessionStock Price UpStock MarketARAMIS GROUPStockARAMI.PA
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com